Considering the enhancement of DNA repair capability is one of the major contributions to resistance in cancer cells, it follows that simultaneous inhibition of PARP activity alongside DNA‐targeting platinum and ruthenium metal complexes could suppress chemoresistance and in addition to heightening sensitivity towards these DNA‐damaging metal complexes. The gene discussed is PARP1; the disease is cancer.